Unknown

Dataset Information

0

A PREVIOUSLY UNKNOWN UNIQUE CHALLENGE FOR INHIBITORS OF SYK ATP-BINDING SITE: ROLE OF SYK AS A CELL CYCLE CHECKPOINT REGULATOR.


ABSTRACT: The identification of SYK as a molecular target in B-lineage leukemia/lymphoma cells prompted the development of SYK inhibitors as a new class of anti-cancer drug candidates. Here we report that induction of the SYK gene expression in human cells causes a significant down-regulation of evolutionarily conserved genes associated with mitosis and cell cycle progression providing unprecedented evidence that SYK is a master regulator of cell cycle regulatory checkpoint genes in human cells. We further show that SYK regulates the G2 checkpoint by physically associating with and inhibiting the dual-specificity phosphatase CDC25C via phosporylation of its S216 residue. SYK depletion by RNA interference or treatment with the chemical SYK inhibitor prevented nocodazole-treated human cell lines from activating the G2 checkpoint via CDC25C S216-phoshorylation and resulted in polyploidy. Our study provides genetic and biochemical evidence that spleen tyrosine kinase (SYK) has a unique role in the activation of the G2 checkpoint in both nonlymphohematopoietic and B-lineage lymphoid cells. This previously unknown role of SYK as a cell cycle checkpoint regulator represents an unforeseen and significant challenge for inhibitors of SYK ATP binding site.

SUBMITTER: Uckun FM 

PROVIDER: S-EPMC4259291 | biostudies-literature |

REPOSITORIES: biostudies-literature

Similar Datasets

| S-EPMC1169059 | biostudies-literature
| S-EPMC6214956 | biostudies-literature
| S-EPMC3410435 | biostudies-literature
| S-EPMC2674095 | biostudies-literature
2013-04-30 | GSE46425 | GEO
| S-EPMC5910849 | biostudies-other
| S-EPMC5358384 | biostudies-literature
| S-EPMC3680490 | biostudies-literature
2005-09-23 | GSE3352 | GEO
| S-EPMC3806263 | biostudies-literature